Publication | Closed Access

Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial

ObesityMetabolic SyndromeNutritionNeutral EffectsFatty AcidsMedicineOmega-3 Fatty AcidDiabetesLipid NutritionType 2Diabetes MellitusPharmacologyDyslipidemia